Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease.
David L SuskindGhassan WahbehStanley A CohenChristopher J DammanJani KleinKim BralyMichele ShafferDale LeePublished in: Digestive diseases and sciences (2016)
The SCD is utilized by many patients as a primary and adjunct therapy for IBD. Most patients perceive clinical benefit to use of the SCD.